A PET scan (positron emission tomography) is an imaging test used to detect cancer, evaluate heart disease, diagnose brain disorders, and track down hidden infections or inflammation. Unlike a standard CT or MRI, which shows the structure of your organs, a PET scan reveals how your tissues are functioning at the molecular level, making it one of the most powerful tools in medicine for catching disease early and monitoring treatment.
How a PET Scan Works
Before the scan, you receive an injection of a tracer, a biologically active molecule tagged with a small amount of radioactive material. The most common tracer is a modified form of glucose. Because cancer cells, active brain tissue, and inflamed areas all consume more energy than surrounding tissue, the tracer concentrates in those spots.
Once the tracer accumulates (typically over about 60 minutes), the radioactive tag begins to decay. It releases a particle called a positron, which almost instantly collides with a nearby electron. That collision produces two high-energy photons that shoot off in exactly opposite directions. A ring of detectors surrounding your body picks up both photons at the same time, and a computer uses hundreds of thousands of these paired signals to build a detailed map of metabolic activity throughout your body.
The result is an image that lights up wherever cells are unusually active. Areas of high tracer uptake can point to tumors, seizure origins, damaged heart muscle, or pockets of infection.
Cancer Detection and Staging
Oncology is by far the most common reason for a PET scan. The test plays a central role in diagnosing cancer, determining how far it has spread (staging), and checking whether treatment is working.
Because cancer cells divide rapidly, they burn through glucose much faster than normal tissue. A PET scan exploits this, highlighting tumors as bright spots against a dimmer background. One of its biggest advantages is the ability to find metastases that other imaging misses entirely. A tumor that has seeded small clusters of cancer cells in distant lymph nodes, bones, or organs may look normal on a CT scan but show up clearly on PET because of the abnormal metabolic activity.
During treatment, PET scans can reveal whether chemotherapy, immunotherapy, or radiation is actually shrinking the tumor’s activity, not just its size. This matters because a tumor can remain the same dimensions on a CT scan while already being metabolically dead inside, or conversely look unchanged while still growing aggressively. Detecting a non-responding tumor early allows your care team to switch strategies before losing valuable time. PET is also used after treatment is finished to watch for recurrence, sometimes catching a returning cancer based on rising metabolic signals before any other test shows a problem.
Brain Disorders
PET scanning gives a unique window into how different brain regions use energy, which makes it valuable for two major neurological conditions: dementia and epilepsy.
In people with memory loss or cognitive decline, a PET scan often reveals characteristic patterns of reduced metabolic activity in specific brain regions. Alzheimer’s disease, for example, tends to produce a distinctive pattern of low activity in the temporal and parietal lobes. Other forms of dementia affect different areas. These patterns help distinguish Alzheimer’s from frontotemporal dementia, Lewy body dementia, and other causes of cognitive decline, which is important because the management strategies differ significantly.
For epilepsy, PET is used when surgery is being considered. The scan can pinpoint the seizure focus, the specific area of the brain where seizures originate, by identifying a zone of abnormally low metabolism between seizures. This is especially helpful when EEG recordings and MRI results are unclear or contradictory. Accurately localizing the focus improves the chances of a successful surgical outcome.
Heart Disease
In cardiology, PET scans serve two main purposes: measuring blood flow through the heart muscle and determining whether damaged tissue is still alive.
PET-based perfusion imaging can quantify exactly how much blood reaches different parts of the heart, both at rest and under stress. This absolute measurement (rather than a relative comparison between regions) makes it particularly good at detecting blockages in the coronary arteries and estimating the overall burden of blood vessel disease, including problems in the tiny vessels that larger tests can miss.
After a heart attack, the scan can also distinguish between heart muscle that is scarred and permanently dead versus muscle that is “hibernating,” alive but not contracting because of poor blood supply. This distinction matters enormously: hibernating muscle can recover function if blood flow is restored through a procedure like bypass surgery or stenting, while scarred tissue cannot. PET helps identify the patients most likely to benefit from those interventions.
Infection and Inflammation
When a patient has a persistent fever with no obvious source, PET scanning can locate hidden infections or inflammatory conditions throughout the body. Infected or inflamed tissue draws in immune cells that consume large amounts of glucose, creating the same kind of metabolic hotspot that tumors produce.
This application is particularly useful for diagnosing vasculitis (inflammation of blood vessel walls), where PET can detect inflamed arteries that look normal on conventional imaging. It also helps identify deep-seated infections like tuberculosis or abscesses and monitor whether anti-inflammatory treatments are working. One caveat: certain infections, such as Epstein-Barr virus, can mimic the appearance of cancer on a PET scan, so results always need to be interpreted alongside lab work and clinical context.
Specialized Tracers Beyond Glucose
While the glucose-based tracer dominates most PET imaging, newer tracers are expanding what the technology can do. One notable example targets a protein found on the surface of prostate cancer cells. This tracer is now widely used for staging prostate cancer, detecting recurrence, and selecting patients for targeted radioactive therapy. In some cases, prostate cancer cells don’t express enough of this surface protein to show up with the specialized tracer, so a glucose-based PET scan is performed alongside it to catch those harder-to-detect lesions. The development of disease-specific tracers is one of the reasons PET imaging continues to grow in clinical importance.
What the Scan Feels Like
The experience is straightforward but takes some time. You’ll need to fast for about six hours beforehand, avoiding all carbohydrates, sugars, and even flavored water or gum, since anything that affects your blood sugar can interfere with the tracer’s distribution. Protein-only meals are fine during the fasting window. If you have diabetes, your blood sugar should be below 160 mg/dL on the day of the scan. Regular prescription medications are fine to take as scheduled.
When you arrive, you’ll get an IV injection of the tracer, then sit quietly in a dimly lit room for about 60 minutes while it circulates and accumulates. Physical activity, even fidgeting, can cause the tracer to concentrate in your muscles instead of the areas your doctor needs to see, so staying still matters. You’ll also be asked to drink plain water before the appointment to stay hydrated.
The scan itself involves lying on a table that slides through a ring-shaped scanner. It’s painless and quieter than an MRI. The entire visit, from check-in to leaving, typically runs about two to three hours.
Radiation Exposure
A standard PET/CT scan delivers an average total radiation dose of about 10 millisieverts (mSv), roughly comparable to a single diagnostic CT scan. About two-thirds of that dose comes from the injected tracer, and the remaining third from the low-dose CT that runs alongside it to provide anatomical landmarks. For context, the average person absorbs about 3 mSv per year from natural background radiation. The dose is considered low-risk for the diagnostic benefit it provides, though it is one reason PET scans are ordered selectively rather than as routine screening.
PET/CT vs. PET/MRI
Most PET scans today are performed as PET/CT, combining the metabolic information from PET with the structural detail of a CT scan in a single session. Newer PET/MRI systems pair the metabolic data with MRI instead, offering better contrast for soft tissues and lower radiation exposure since MRI uses no ionizing radiation at all. PET/MRI is showing particular promise for brain imaging, head and neck cancers, and prostate cancer, where MRI’s superior ability to distinguish soft tissue boundaries gives it an edge over CT. Availability is still limited to larger medical centers, but the technology is gradually becoming more widespread.